Butatron Patent Expiration

Butatron Petitions

Details of Butatron's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
Cross Vetpharm Group, Ltd. Filed 09 Feb, 2004 The generic product will have a different physical form, powder, whereas the pioneer approved product is a tablet.

About Butatron

Butatron is a drug owned by BIMEDA ANIMAL HEALTH LIMITED . Butatron uses Phenylbutazone as the active ingredient.

Active Ingredient:

Butatron uses Phenylbutazone as the active ingredient. Check out other Drugs and Companies using Phenylbutazone ingredient.